Page last updated: 2024-08-23

pravastatin and Insulin Resistance

pravastatin has been researched along with Insulin Resistance in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (6.45)18.2507
2000's15 (48.39)29.6817
2010's14 (45.16)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Favero, BC; García-Arevalo, M; Gomes-Marcondes, MCC; Lorza-Gil, E; Oliveira, HCF1
Beck, B; Donner, D; du Toit, EF; Headrick, JP; Oi, M; Peart, J; Wendt, L1
Hori, E; Imaeda, K; Kikuchi, C; Matsunaga, T; Okayama, N; Suzuki, T1
Ganesan, S; Ito, MK1
Choi, H; Han, SH; Koh, KK; Lee, K; Lee, Y; Lim, S; Oh, PC; Quon, MJ; Sakuma, I; Shin, EK1
Zhao, SP; Zhao, W1
Kokkola, T; Modi, S; Yaluri, N1
Han, SH; Kim, SJ; Koh, KK; Lee, Y; Park, JB; Quon, MJ; Shin, EK1
Huang, CN; Lee, IT; Lee, WJ; Ou, HC; Sheu, WH1
Baker, WL; Coleman, CI; Talati, R; White, CM1
Harada, M; Otani, M; Otsuki, M; Yamamoto, M1
Koh, KK; Quon, MJ; Sakuma, I1
Arai, H; Minami, M; Murayama, T; Tamura, Y; Yokode, M1
Atanassova, P; Bełtowski, J; Chaldakov, GN; Jamroz-Wiśniewska, A; Kula, W; Rusek, M1
Choi, H; Han, SH; Koh, KK; Lee, K; Quon, MJ; Sakuma, I; Shin, EK1
Andreotti, F; Basile, F; Biaggi, A; Bracaglia, M; Caruso, A; De Waure, C; Di Cesare, C; Di Nicuolo, F; Di Simone, N; Di'Ipolito, S; Donati, L; Ianniello, F; Labianca, A; Paradisi, G; Quagliozzi, L; Viggiano, M1
Faust, M1
Güçlü, F; Hekimsoy, Z; Kirmaz, C; Ozmen, B1
Amm-Azar, M; Azar, RR; Gannagé-Yared, MH; Germanos-Haddad, M; Halaby, G; Khalifé, S; Neemtallah, R1
Matsui, T; Sato, T; Takeuchi, M; Yamagishi, S1
Ichihara, K; Kanda, M; Kasai, T; Keimatsu, N; Satoh, K; Sun, F; Takaguri, A1
Hayashi, J; Kikuchi, K; Maeda, N; Okada, K; Sawayama, Y; Tatsukawa, M1
Kadonosono, K; Okamura, A; Takano, T; Utsunomiya, H; Yamakawa, T1
Chen, Y; Kohno, M; Kosaka, H; Mizukawa, M; Ohmori, K; Shinomiya, K; Yoshida, J; Zeng, Y; Zhang, L1
Dagli, N; Karaca, I; Yavuzkir, M1
Fujioka, D; Kawabata, K; Kitta, Y; Kobayashi, T; Kodama, Y; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Takano, H; Yano, T1
Chen, M; Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Ohtsubo, H; Sunagawa, K1
Chien, YH; Lee, WJ; Lee, WL; Liang, KW; Sheu, WH; Tang, YJ; Tsou, SS1
Albarrán, OG; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E1
Horikoshi, H; Ito, T; Shiomi, M; Tsujita, Y; Tsukada, T1
Dumont, AS; Dumont, RJ; Fedak, PM; Hyndman, ME; Kassell, NF; Sutherland, GR; Verma, S1

Reviews

2 review(s) available for pravastatin and Insulin Resistance

ArticleYear
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.
    Diabetes research and clinical practice, 2010, Volume: 87, Issue:1

    Topics: Anticholesteremic Agents; Blood Glucose; Blood Pressure; Body Size; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Patient Selection; Pravastatin; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Triglycerides

2010
Differential metabolic effects of distinct statins.
    Atherosclerosis, 2011, Volume: 215, Issue:1

    Topics: Adiponectin; Animals; Atorvastatin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Fluorobenzenes; Heptanoic Acids; Homeostasis; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mice; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides

2011

Trials

8 trial(s) available for pravastatin and Insulin Resistance

ArticleYear
Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.
    Diabetes, 2013, Volume: 62, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Body Mass Index; Brachial Artery; C-Reactive Protein; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Lipids; Male; Middle Aged; Phenotype; Pravastatin; Tetrazoles; Treatment Outcome; Valine; Valsartan

2013
Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.
    Atherosclerosis, 2009, Volume: 204, Issue:2

    Topics: Adiponectin; C-Reactive Protein; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin; Insulin Resistance; Leptin; Lipoproteins; Male; Middle Aged; Pravastatin; Simvastatin; Treatment Outcome; Vasodilation

2009
Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients.
    International journal of cardiology, 2013, Jun-20, Volume: 166, Issue:2

    Topics: Female; Fluorobenzenes; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides

2013
Effect of pravastatin on endothelial function and endothelial progenitor cells in healthy postmenopausal women.
    Clinical and experimental obstetrics & gynecology, 2012, Volume: 39, Issue:2

    Topics: Anticholesteremic Agents; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Endothelium, Vascular; Female; Humans; Insulin Resistance; Lipoproteins, LDL; Middle Aged; Multivariate Analysis; Postmenopause; Pravastatin; Stem Cells; Triglycerides

2012
Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.
    Metabolism: clinical and experimental, 2005, Volume: 54, Issue:7

    Topics: Adiponectin; Adult; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Leptin; Male; Middle Aged; Placebos; Pravastatin; Reference Values

2005
Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
    Endocrine journal, 2007, Volume: 54, Issue:1

    Topics: Aged; Anticholesteremic Agents; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Hemoglobins; Humans; Hypercholesterolemia; Imidazoles; Insulin Resistance; Male; Middle Aged; Pravastatin; Resins, Synthetic

2007
The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation.
    Inflammation, 2007, Volume: 30, Issue:6

    Topics: Administration, Oral; Adult; Aged; Anticholesteremic Agents; Azetidines; Blood Glucose; C-Reactive Protein; Cholesterol; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Pravastatin; Treatment Outcome; Triglycerides

2007
Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia.
    Clinica chimica acta; international journal of clinical chemistry, 2008, Volume: 390, Issue:1-2

    Topics: Anticholesteremic Agents; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation; Insulin Resistance; Male; Middle Aged; Pravastatin; Triglycerides

2008

Other Studies

21 other study(ies) available for pravastatin and Insulin Resistance

ArticleYear
Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice.
    Journal of translational medicine, 2019, 08-27, Volume: 17, Issue:1

    Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Line; Diabetes Mellitus, Experimental; Fasting; Female; Glucose Intolerance; Homeostasis; Hypercholesterolemia; Insulin; Insulin Resistance; Insulin Secretion; Mice, Inbred C57BL; Models, Biological; Muscle Fibers, Skeletal; Muscle Proteins; Myotoxicity; Oxidative Stress; Phosphorylation; Pravastatin; Proteolysis; Receptors, LDL; Signal Transduction; Superoxides

2019
Pravastatin improves risk factors but not ischaemic tolerance in obese rats.
    European journal of pharmacology, 2018, May-05, Volume: 826

    Topics: Animals; Blood Glucose; Body Weight; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Insulin Resistance; Lipid Peroxidation; Male; Mitochondria; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Obesity; Pravastatin; Rats; Rats, Wistar; Risk Factors

2018
[Effect of Statins on Glycemic Status and Plasma Adiponectin Concentrations in Patients with Type 2 Diabetes Mellitus and Hypercholesterolemia].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, May-01, Volume: 139, Issue:5

    Topics: Adiponectin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Molecular Weight; Pravastatin

2019
Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes.
    Metabolic syndrome and related disorders, 2013, Volume: 11, Issue:4

    Topics: 3T3-L1 Cells; Adipocytes; Animals; Anticholesteremic Agents; Azetidines; Diabetes Mellitus; Drug Interactions; Ezetimibe; Glucose Transporter Type 4; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mice; Pravastatin; Simvastatin; Ubiquinone

2013
Different effects of statins on induction of diabetes mellitus: an experimental study.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Atorvastatin; Cell Cycle; Cell Survival; Cells, Cultured; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucose; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Muscle, Skeletal; Pravastatin; Quinolines; Rosuvastatin Calcium; Signal Transduction; Structure-Activity Relationship

2015
Simvastatin induces insulin resistance in L6 skeletal muscle myotubes by suppressing insulin signaling, GLUT4 expression and GSK-3β phosphorylation.
    Biochemical and biophysical research communications, 2016, 11-11, Volume: 480, Issue:2

    Topics: Animals; Cell Line; Cholesterol; Glucose; Glucose Transporter Type 4; Glycogen; Glycogen Synthase Kinase 3 beta; Insulin; Insulin Resistance; Muscle Fibers, Skeletal; Phosphorylation; Pravastatin; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Simvastatin

2016
Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia.
    Metabolism: clinical and experimental, 2009, Volume: 58, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Blood Glucose; C-Reactive Protein; Cell Adhesion; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Monocytes; Patient Selection; Pravastatin; Triglycerides; Young Adult

2009
Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat.
    British journal of pharmacology, 2010, Jan-01, Volume: 159, Issue:2

    Topics: Adipose Tissue, White; Animals; Apoptosis; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Organ Size; Pancreas; Peroxidase; Pravastatin; Rats; Rats, Long-Evans; Superoxide Dismutase; Time Factors; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha

2010
Differential effect of statins on diabetic nephropathy in db/db mice.
    International journal of molecular medicine, 2011, Volume: 28, Issue:5

    Topics: Adiposity; Albuminuria; Animals; Blood Pressure; Body Weight; Creatinine; Diabetic Nephropathies; Fluorobenzenes; Insulin Resistance; Male; Mice; Oxidative Stress; Pravastatin; Pyrimidines; Quinolines; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides

2011
Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.
    Atherosclerosis, 2011, Volume: 219, Issue:2

    Topics: Adipokines; Adipose Tissue; Animals; Atorvastatin; Biomarkers; Blood Glucose; Calcifediol; Calcitriol; Cholecalciferol; Fasting; Fatty Acids, Nonesterified; Glucose Clamp Technique; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Pravastatin; Pyrroles; Rats; Rats, Wistar; Time Factors

2011
[Statin treatment in type 2 diabetes. Is it a must today?].
    MMW Fortschritte der Medizin, 2003, Feb-27, Volume: 145, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 2; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Insulin Resistance; Life Style; Middle Aged; Placebos; Pravastatin; Primary Prevention; Risk Factors; Simvastatin

2003
Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2004, Volume: 58, Issue:10

    Topics: Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Metabolic Syndrome; Middle Aged; Pravastatin

2004
Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Medical hypotheses, 2006, Volume: 66, Issue:3

    Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Models, Biological; Models, Theoretical; Obesity; Pravastatin

2006
HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:11

    Topics: Animals; Atorvastatin; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Glucose Intolerance; Glucose Tolerance Test; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Pravastatin; Pyrroles; Rats; Rats, Wistar; Simvastatin

2005
Pravastatin improves insulin resistance in dyslipidemic patients.
    Journal of atherosclerosis and thrombosis, 2005, Volume: 12, Issue:6

    Topics: Aged; Anticholesteremic Agents; Carotid Arteries; Dyslipidemias; Female; Glucose; Humans; Insulin Resistance; Male; Middle Aged; Pravastatin; Ultrasonography

2005
Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:1

    Topics: Adiponectin; Adipose Tissue; Animals; Anticholesteremic Agents; Atorvastatin; Chemokine CCL2; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Glucose; Heptanoic Acids; Hypertriglyceridemia; Insulin Resistance; Leptin; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Pyrroles; Rats; Rats, Long-Evans; Rats, Mutant Strains; RNA, Messenger; Transforming Growth Factor beta1; Ventricular Dysfunction, Left

2007
Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Acetylcysteine; Adiponectin; Administration, Oral; Animals; Animals, Newborn; Antioxidants; Blood Glucose; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Ligation; Lipids; Male; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Pravastatin; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Recombinant Proteins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Tumor Necrosis Factor-alpha

2007
Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:10

    Topics: Angioplasty, Balloon; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Cell Count; Cell Proliferation; Fructose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Immunohistochemistry; Insulin Resistance; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Stem Cells; Tetrazoles

2007
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
    American journal of hypertension, 1998, Volume: 11, Issue:7

    Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiovascular Diseases; Cholesterol; Coronary Vessels; Disease Models, Animal; Disease Progression; Dogs; Drug Therapy, Combination; Heart; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Myocardium; Obesity; Pravastatin; Triglycerides

1998
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
    Atherosclerosis, 1999, Volume: 142, Issue:2

    Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Blood Glucose; Cholesterol, LDL; Chromans; Coronary Vessels; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Glucose Tolerance Test; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperinsulinism; Hyperlipoproteinemia Type II; Hypoglycemic Agents; Insulin Resistance; Male; Pravastatin; Rabbits; Thiazoles; Thiazolidinediones; Troglitazone; Xanthomatosis

1999
Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin.
    Journal of neurosurgery, 2001, Volume: 95, Issue:3

    Topics: Animals; Carotid Stenosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Hypertension; Insulin Resistance; Male; Nitric Oxide; Pravastatin; Rats; Rats, Sprague-Dawley; Risk Factors; Stroke; Vascular Resistance

2001